Nymbl Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
26
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$984K
- Investors
-
28
Nymbl General Information
Description
Developer of a physical and cognitive training application designed to facilitate fall reduction. The company's application focuses on integrating with dual-tasking fall reduction software that helps users measure their health care status and also offers physical training modules and trains reflexive balance through exercises guided via smartphone technology, enabling older adults to measure, track, and improve balance to boost their confidence and enhance their quality of life.
Contact Information
Website
www.nymblscience.comCorporate Office
- 2000 South Colorado Boulevard
- Suite 240
- Denver, CO 80222
- United States
Corporate Office
- 2000 South Colorado Boulevard
- Suite 240
- Denver, CO 80222
- United States
Nymbl Timeline
Nymbl Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Later Stage VC | 12-Sep-2025 | $984K | Completed | Generating Revenue | ||
| 12. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 11. Later Stage VC (Series B) | 17-Oct-2023 | Completed | Generating Revenue | |||
| 10. Later Stage VC | 17-Oct-2022 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | 01-Jan-2021 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series A) | 24-Sep-2020 | Completed | Generating Revenue | |||
| 7. Seed Round | 24-Sep-2020 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 01-Jan-2019 | Completed | Generating Revenue | |||
| 5. Grant | 24-Oct-2017 | $45K | $20K | Completed | Generating Revenue | |
| 4. Grant | 01-Aug-2017 | $52.2K | $20K | Completed | Generating Revenue |
Nymbl Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A | ||||||||
| Seed-3 | ||||||||
| Seed-2 | 10,860,364 | $0.000100 | 6% | $0.07 | $0.07 | 1x | $0.07 | 4.47% |
| Seed-1 | 11,759,090 | $0.000100 | 6% | $0.04 | $0.04 | 1x | $0.04 | 4.84% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Nymbl Comparisons
Industry
Financing
Details
Nymbl Competitors (12)
One of Nymbl’s 12 competitors is Savonix, a Formerly VC-backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Savonix | Formerly VC-backed | San Francisco, CA | ||||
| CNS Vital Signs | Corporation | Morrisville, NC | ||||
| Muse (Monitoring Equipment) | Venture Capital-Backed | Toronto, Canada | ||||
| Sleep Reset | Venture Capital-Backed | San Francisco, CA | ||||
| Remente | Venture Capital-Backed | Göteborg, Sweden |
Nymbl Patents
Nymbl Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021207909-A1 | Systems and methods for adjusting training data based on sensor data | Inactive | 17-Jan-2020 | ||
| EP-4090240-A2 | Systems and methods for adjusting training data based on sensor data | Pending | 17-Jan-2020 | ||
| EP-4090240-A4 | Systems and methods for adjusting training data based on sensor data | Pending | 17-Jan-2020 | ||
| JP-2023510077-A | Systems and methods for adjusting training data based on sensor data | Pending | 17-Jan-2020 | ||
| US-12518861-B2 | Systems and methods for adjusting training data based on sensor data | Active | 17-Jan-2020 | G16H20/30 |
Nymbl Signals
Nymbl Investors (28)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 450 Ventures | Corporate Venture Capital | Minority | ||
| Accident Compensation Corporation | Limited Partner | Minority | ||
| Denver Ventures | Venture Capital | Minority | ||
| FemHealth Ventures | Venture Capital | Minority | ||
| Forefront Venture Partners | Venture Capital | Minority |
Nymbl FAQs
-
When was Nymbl founded?
Nymbl was founded in 2014.
-
Where is Nymbl headquartered?
Nymbl is headquartered in Denver, CO.
-
What is the size of Nymbl?
Nymbl has 26 total employees.
-
What industry is Nymbl in?
Nymbl’s primary industry is Other Healthcare Technology Systems.
-
Is Nymbl a private or public company?
Nymbl is a Private company.
-
What is Nymbl’s current revenue?
The current revenue for Nymbl is .
-
How much funding has Nymbl raised over time?
Nymbl has raised $22.7M.
-
Who are Nymbl’s investors?
450 Ventures, Accident Compensation Corporation, Denver Ventures, FemHealth Ventures, and Forefront Venture Partners are 5 of 28 investors who have invested in Nymbl.
-
Who are Nymbl’s competitors?
Savonix, CNS Vital Signs, Muse (Monitoring Equipment), Sleep Reset, and Remente are some of the 12 competitors of Nymbl.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process